The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (2 analysts) rates it buy, with a mean price target of $174.
FTI Consulting, Inc.
FCN · the NYSE · USD · Market cap $4.2B · 8,170 employees
FTI Consulting, Inc.
PASS · Titan Ethical · score 70.0At the last full screen
2026-08-25
Screened 2026-08-25 · the tape above runs as of 16:37 UTC · 29 Aug · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
FTI Consulting, Inc. holds its Distribution at $151.68. The statistical read favours the sellers, held for 27 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 27 days |
| Price at the screen | $151.68 |
| Valuation | 18.36 trailing · 13.87 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | -0.05 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 17.95% | Below 33% | Interest-bearing debt is just 18.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 29.49% | Below 49% | Money owed to the company is 29.5% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.19% | Below 5% | Only 0.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-08-25 screen. The gold marker is the market price at the same screen. A 18.7% margin of safety to the base estimate.
Third-party analyst targets: 2 covering, consensus Buy. The average target sits +16% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-25 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsConsulting Advice That Rarely Moves the Needle
Picture a firm parachuted into boardrooms to untangle lawsuits, clean up balance sheets or smooth a crisis. FTI Consulting does exactly that across corporate finance, forensics and strategy. The business clears a clean ethical screen and posts a respectable 14 percent return on equity, yet the numbers never quite add up to an edge.
Revenue is expanding at a modest 10 percent clip while net margins sit at just 7 percent. At 14.6 times forward earnings the shares trade close to our own fair value of 180 dollars, leaving only an 11 percent margin of safety from the current 162.55 dollar price. Two analysts call it a buy with a 172 dollar target, but that still fails to clear the bar we set for a genuine opportunity.
Growth looks steady rather than special and the unknown competitive moat leaves little room for surprise upside. Cyclical swings in litigation and restructuring work could easily compress those already thin margins. Analysis, not advice.
| Forward P/E | 13.9xexpensive even after accounting for its growth |
| Trailing P/E | 18.4xreasonably valued |
| EPS, trailing | 8.26 |
| EPS, forward | 10.93 |
| Revenue growth | +5.3%slow but positive growth |
| Profit margin | 6.4%thin but positive margins |
| Return on equity | 15.6%a solid return on shareholder capital |
| FCF yield | 6.92% |
| Debt to equity | 0.95moderate, manageable leverage |
| Current ratio | 2.03comfortably covers its short-term bills |
| Beta | -0.05barely tracks the market's swings |
| Short interest, float | 0.14% |
| 52-week range | 137.65 - 189.30 |
| Market cap | $4.2B |
| Employees | 8,170 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeFCN trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (2 analysts) rates it buy, with a mean price target of $174.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 14 Apr2026 | Thomas Kean Jr | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $159.09 | +0.7% | · | $1,007 | +0.7% |
| 2 months | $176.26 | -9.1% | · | $909 | -9.1% |
| 3 months | $162.43 | -1.4% | · | $986 | -1.4% |
| 6 months | $168.33 | -4.9% | · | $951 | -4.9% |
| 1 year | $159.70 | +0.3% | · | $1,003 | +0.3% |
| 2 years | $212.42 | -24.6% | · | $754 | -24.6% |
| 3 years | $191.17 | -16.2% | · | $838 | -16.2% |
| 5 years | $140.99 | +13.6% | · | $1,136 | +13.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever FCN does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.